Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

Former North Carolina governor, UNC law school alum Jim Hunt dies at 88
Former Gov. Jim Hunt, who redefined the office of governor in North Carolina, championed public education and helped focus the state's economy on high-tech industries,...
Sat Dec 20, 2025

Best moments from ESPN documentary "Boo-Yah: A Portrait of Stuart Scott"
In 1984, Stuart Scott began attending the University of North Carolina, where he studied journalism. He became a member of Alpha Phi Alpha Fraternity Inc.,...
Thu Dec 18, 2025

UNC grad documents post-Helene recovery
In addition to Carolina’s Spring Commencement, Max Feliu ’25 had another May date circled on his calendar. The filmmaker’s nine-minute documentary on life after Hurricane...
Thu Dec 18, 2025

UNC Athletics Celebrates The Season With Team IMPACT
Carolina Athletics welcomed members of Team IMPACT and their families for a fun-filled day of holiday activities with student-athletes from various programs on Saturday. The...
Tue Dec 16, 2025